STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PHIO PHIO PHARMACEUTICALS CORPORATION StockScouter® Report

4

StockScouter® Score

PHIO PHARMACEUTICALS CORPORATION, a micro cap company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive

 

Concerns

  • The multi-period measure of relative price change and consistency is well below average. Negative
  • The 50-day moving average for PHIO is significantly below its 200-day moving average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 60% done.
Low
High

Core Model Grades

A
A
N/A
F

Previous Ratings

4
2
3